These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29953477)

  • 1. Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus?
    Santi D; Locaso M; Granata AR; Trenti T; Roli L; Pacchioni C; Rochira V; Carani C; Simoni M
    PLoS One; 2018; 13(6):e0199299. PubMed ID: 29953477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial.
    Santi D; Granata AR; Guidi A; Pignatti E; Trenti T; Roli L; Bozic R; Zaza S; Pacchioni C; Romano S; Nofer JR; Rochira V; Carani C; Simoni M
    Eur J Endocrinol; 2016 Apr; 174(4):513-22. PubMed ID: 26792933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic administration of the phosphodiesterase inhibitor vardenafil on serum levels of adrenal and testicular steroids in men with type 2 diabetes mellitus.
    Santi D; Granata AR; Pignatti E; Trenti T; Roli L; Bozic R; Zaza S; Pacchioni C; Rochira V; Carani C; Simoni M
    Endocrine; 2017 May; 56(2):426-437. PubMed ID: 27515804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
    Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
    J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
    Echouffo-Tcheugui JB; Kengne AP
    Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil.
    Azab S; Aoud H; Nabil N
    Int J Impot Res; 2017 Mar; 29(2):82-85. PubMed ID: 27904146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vardenafil in men with stable statin therapy and dyslipidemia.
    Miner M; Gilderman L; Bailen J; Cook D; Dawson K; Stanislaus M; Beresford E; Barnes A
    J Sex Med; 2008 Jun; 5(6):1455-67. PubMed ID: 18373526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction.
    Corona G; Rastrelli G; Silverii A; Monami M; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2013 Apr; 10(4):1114-23. PubMed ID: 23347470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with erectile dysfunction and cardiovascular or metabolic conditions.
    Van Ahlen H; Zumbé J; Stauch K; Hanisch JU
    J Sex Med; 2010 Sep; 7(9):3161-9. PubMed ID: 20646189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.
    Sperling H; Gittelman M; Norenberg C; Ulbrich E; Ewald S
    J Sex Med; 2011 Jan; 8(1):261-71. PubMed ID: 20807322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction.
    Ziegler D; Merfort F; Van Ahlen H; Yassin A; Reblin T; Neureither M
    J Sex Med; 2006 Sep; 3(5):883-891. PubMed ID: 16942532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.